Behavioural evidence for cholecystokinin-dopamine D1 receptor interactions in the rat

European Journal of Pharmacology

Volumn 298, Issue 1, 1996, Pages 7-15

  Van Kampen, Jackalina ^a   Frydryszak, Hanna ^a   Stoessl, A Jon ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Cholecystokinin; Dopamine; Dopamune D1 receptor; Grooming; Rat; Vacuous chewing movement

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; DEVAZEPIDE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; TETRAGASTRIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG ANTAGONISM; GROOMING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MASTICATION; NONHUMAN; OROFACIAL DYSKINESIA; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; RAT; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030032210     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00767-9     Document Type: Article

References (68)

1. Altar, C.A. and W.C. Boyar, 1989, Brain CCK-B recepors mediate the suppression of dopamine release by cholecystokinin, Brain Res. 483, 321.
2. Altar, C.A., W.C. Boyar, E. Oei and P.L. Wook, 1988, Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release, Brain Res. 460, 76.
3. Boyce, S., N.M.J. Rupniak, M. Steventon and S.D. Iversen, 1990, CCK-8S inhibits 1-dopa-induced dyskinesias in parkinsonian squirrel monkeys, Neurology 40, 717.
4. Burt, S.R., I. Creese and S.H. Snyder, 1977, Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain, Science 196, 326.
5. Clow, A., P. Jenner and C.D. Marsden, 1979, Changes in dopamine-mediated behavior during one year's neuroleptic administration, Eur. J. Pharmacol. 57, 365.
6. Crawley, J.N., 1994, Cholecystokinin modulates dopamine-mediated behaviors: differential actions in medial posterior versus anterior nucleus accumbens, Ann. NY Acad. Sci. 713, 138.
7. Crawley, J.N. and R.L. Corwin, 1994, Biological actions of cholecystokinin, Peptides 15, 731.
8. Crawley, J.N. and J.S. Schwaber, 1984, Abolition of the behavioral effects of cholecystokinin following bilateral radiofrequency lesions of the parvocellular subdivision of the nucleus tractus solitarius, Brain Res. 295, 289.
9. Crawley, J.N., S.E. Hays and S.M. Paul, 1981, Vagotomy abolishes the inhibitory effects of cholecystokinin on rat exploratory behaviors, Eur. J. Pharmacol. 73, 379.
10. Crawley, J.N., J.A. Stivers, L.K. Blumstein and S.M. Paul, 1985, Cholecystokinin potentiates dopamine-mediated behaiors: evidence for modulation specific to a site of coexistence, J. Neurosci. 5, 1972.
11. Daugé, V., A. Dor, J. Feger and B.P. Roques, 1989, The behavioral effects of CCK-8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat, Eur. J. Pharmacol. 163, 25.
12. Derrien, M., I. McCort-Tranchepain, B. Ducos, B.P. Roques and C. Durieux, 1994, Heterogeneity of CCK-B receptors involved in animal models of anxiety, Pharmacol. Biochem. Behav. 49, 133.
13. B receptors in the control of feeding in rodents, in: Multiple Cholecystokinin Receptors, ed. C.T. Dourish, S.J. Cooper, S.D. Iversen and L.L. Iversen (Oxford University Press, Oxford) p. 234.
14. 1 agonist-induced behaviour and cAMP efflux by CCK-8S, in: Multiple Cholecystokinin Receptors, ed. C.T. Dourish, S.J. Cooper, S.D. Iversen and L.L. Iversen (Oxford University Press, Oxford) p. 417.
15. 2 agonist LY 171555 on oral movements in rats, Psychopharmacoloy 96, 253.
16. Fibiger, H.C. and K.G. Lloyd, 1984, Neurobiological substrates of tardive dyskinesia: the GABA hypothesis, Trends Neurosci. 7, 462.
17. Freeman, A.S. and L.A. Chiodo, 1988, Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons, Brain Res. 439, 266.
18. 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in number of binding sites, Acta Physiol. Scand. 113, 567.
19. Glenthoj, B., R. Hemmingsen, P. Allerup and T.G. Bolwig, 1990, Intermittent versus continuous neuroleptic in a rat model, Eur. J. Pharmacol. 190, 275.
20. Hamamura, T., Y. Kazahaya and S. Otsuki, 1989, Ceruletide suppresses endogenous dopamine release via vagal afferent system, studies by in vivo intracerebral dialysis, Brain Res. 483, 78.
21. Hashimoto, T. and N. Yanagisawa, 1990, Acute reduction and long-term improvement of chorea with ceruletide (cholecystokinin analogue), J. Neurol. Sci. 100, 178.
22. Herbert, H., 1992, Evidence for projections from medullary nuclei onto serotonergic and dopaminergic neurons in the midbrain dorsal raphe nucleus of the rat, Cell Tissue Res. 270, 149.
23. Hill, D.R., N.J. Campbell, T.M. Shaw and G.N. Woodruff, 1987, Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists, J. Neurosci. 7, 2967.
24. 3H-MK-329, J. Neurosci. 10, 1070.
25. Hökfelt, T., J.F. Rehfeld, L. Skirboll, B. Ivemark, M. Goldstein and K. Markey, 1980, Evidence for coexistence of dopamine and CCK in meso-limbic neurones, Nature 285, 476.
26. Hommer, D.W., M. Palkovits, J.N. Crawley, S.M. Paul and L.R. Skirboll, 1985, Cholecystokinin excitation in the substantia nigra: evidence for peripheral and central components, J. Neurosci. 5, 1387.
27. Hommer, D.W., G. Stoner, J.N. Crawley and S.M. Paul, 1986, Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype, J. Neurosci. 6, 3039.
28. Kane, J.M. and J.M. Smith, 1982, Tardive dyskinesia: prevalence and risk factors, Gen. Psychiatry 39, 473.
29. Kariya, K., J. Tanaka and M. Nomura, 1994, Systemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens: a microdialysis study in freely moving rats, Brain Res. 657, 1.
30. Kastin, A.J., C. Nissen, A.V. Schally and D.H. Coy, 1979, Additional evidence that small amounts of a peptide can cross the blood-brain barrier, Pharmacol. Biochem. Behav. 11, 717.
31. Kihara, T., M. Ikeda, N. Ibii and A. Matsushita, 1992, Ceruletide, a CCK-like peptide, attenuates dopamine release from the rat striatum via a central site of action, Brain Res. 588, 270.
32. Leslie, R.A., D.G. Gwyn and D.A. Hopkins, 1982, The central distribution of the cervical vagus nerve and gastric afferent and efferent projections in the rat, Brain Res. Bull. 8, 37.
33. Levy, A.D., R.E. See, E.D. Levin and G.D. Ellison, 1987, Neuroleptic-induced oral movements in rats: methodological issues, Life Sci. 41, 1499.
34. Mansbach, R.S. and D.N. Lorenz, 1983, Cholecystokinin (CCK-8) elicits prandial sleep in rats, Physiol. Behav. 30, 179.
35. Markstein, R. and T. Hökfelt, 1984, Effects of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleus, J. Neurosci. 4, 570.
36. Marshall, F.H., S. Barnes, J. Hughes, G.N. Woodruff and J.C. Hunter, 1991, Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms, J. Neurochem. 56, 917.
37. 1-receptor agonist SKF 38393, Jpn. J. Pharmacol. 60, 141.
38. Molloy, A.G. and J.L. Waddington, 1987, Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK&F 38393 and its R- and S-enantioners, Psychopharmacology 92, 164.
39. Moran, T.H., P.H. Robinson, M.S. Goldrich and P.R. McHugh, 1986, Two brain cholecystokinin receptors: implications for behavioral actions, Brain Res. 362, 175.
40. Moroji, T. and Y. Hagino, 1986, A behavioral pharmacological study on CCK-8 related peptides in mice, Neuropeptides 8, 273.
41. 3H-dopamine binding by cholecystokinin octapeptide (CCK-8), Peptides 3, 539.
42. Nishikawa, T., M. Tanaka, A. Tsuda, H. Kuwahara, I. Koga and Y. Uchida, 1986, Effects of ceruletide on tardive dyskinesia: a pilot study of quantitative computer analyses on electomyogram and microvibration, Psychopharmacology 90, 5.
43. Norgren, R., 1978, Projections from the nucleus of the solitary tract in the rat, Neuroscience 3, 207.
44. Oldendorf, W.H., 1981, Blood-brain barrier permeability to peptides: pitfalls in measurement, Peptides 2, Suppl. 2, 109.
45. O'Neill, M.F., S. Kawamura and C.T. Dourish, 1992, Behavioural analysis of the effects of CCK agonists and antagonists on opiod analgesia, Neurosci. Lett. 42, S59.
46. Palkovits, M., J.Z. Kiss, M.C. Beinfeld and T.H. Williams, 1982, Cholecystokinin in the nucleus of the solitary tract of the rat: evidence for its vagal origin. Brain Res. 252, 386.
47. Phillips, A.G., C.D. Blaha, H.C. Fibiger and R.F. Lane, 1988, Interactions between mesolimbic dopamine neurons, cholecystokinin and neurotensin: evidence using in vivo voltammetry, Ann. NY Acad. Sci. 537, 347.
48. Ricardo, J.A. and E.T. Koh, 1978, Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala and other forebrain structures in the rat, Brain Res. 153, 1.
49. Ruggeri, M., U. Ungerstedt, L.F. Agnati, V. Mutt, A. Härfstrand and K. Fuxe, 1987, Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat, Neurochem. Int. 10, 509.
50. Savasta, M., J.M. Palacios and G. Mengod, 1990, Regional distribution of the messenger RNA coding for the neuropeptide cholecystokinin in the human brain examined by in situ hybridization, Neuroscience 29, 363.
51. Schiffmann, S.N. and J.J. Vanderhaeghen, 1991, Distribution of cells containing mRNA encoding for cholecystokinin in the rat central nervous system, J. Comp. Neurol. 304, 219.
52. Seroogy, K., M. Schalling, S. Brené, Å. Dagerlind, S.Y. Chai, T. Hökfelt, H. Persson, M. Brownstein, R. Huan, J. Dixon, D. Filer, D. Schlessinger and M. Goldstein, 1989, Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studied using in situ hybridization combined with immunohistochemistry, Exp. Brain Res. 74, 149.
53. Skirboll, L.R., A.A. Grace, D.W. Hommer, J. Rehfeld, M. Goldstein, T. Hökfelt and B.S. Bunney, 1981, Peptide monamine coexistence: studies of actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons, Neuroscience 6, 2111.
54. Snyder, G.L., G. Fisone, P. Morino, V. Gundersen, O.P. Ottersen, T. Hökfelt and P. Greengard, 1993, Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum, Proc. Natl. Acad. Sci. USA 90, 11277.
55. Stoessl, A.J. and E. Polanski, 1993, Neuroleptic-induced chewing movements in the rat are suppressed by peripherally but not centrally administered CCK and abolished by bilateral subdiaphragmatic vagotomy, Neuropharmacology 32, 555.
56. Stoessl, A.J., C.T. Dourish and S.D. Iversen, 1987, Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra, Psychopharmacology 93, 336.
57. Stoessl, A.J., C.T. Dourish and S.D. Iversen, 1989, Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective D1 and D2 receptor antagonists, Psychopharmacology 98, 372.
58. Studler, J.M., M. Reibaud, D. Herve, G. Blanc, J. Glowinski and J.P. Tassin, 1986, Opposite effects of sulfated cholecystokinin on DA-sensitive adenylate cyclase in two areas of the rat nucleus accumbens, Eur. J. Pharmacol. 126, 125.
59. Vaccarino, F.G. and J. Rankin, 1989, Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function, Behav. Neurosci. 103, 831.
60. 3H-cholecystokinin as radioligand, J. Neurosci. 4, 1021.
61. Vickroy, T.W., B.R. Bianchi, J.F. Kerwin, H. Kopecka and A.M. Nadzan, 1988, Evidence that type A CCK receptors facilitate dopamine efflux in rat brain, Eur. J. Pharmacol. 93, 63.
62. Wang, Z.J., Z.R. Rao and J.W. Shi, 1992, Tyrosine hydroxylase-, neurotensin-, or cholecystokinin-containing neurons in the nucleus tractus solitarii send projection fibers to the nucleus accumbens in the rat, Brain Res. 578, 347.
63. Wank, S.A., R. Harkins, R.T. Jensen, H. Shapira, A. de Weerth and T. Slattery, 1992a, Purification, molecular cloning and functional expression of the cholecystokinin receptor from rat pancreas, Proc. Natl. Acad. Sci. USA 89, 3125.
64. Wank, S.A., J.R. Pisegna and A. De Weerth, 1992b, Brain and gastro-intestinal cholecystokinin receptor family: structure and functional expression, Proc. Natl. Acad. Sci. USA 89, 8691.
65. Wank, S.A., J.R. Pisegna and A. De Weerth, 1994, Cholecystokinin receptor family: molecular cloning, structure and functional expression in rat, guinea pig and human, Ann. NY Acad. Sci. 713, 49.
66. Wu, T. and H. Wang, 1994, CCK-8 excites substantia nigra dopaminergic neurons by increasing a cationic conductance, Neurosci. Lett. 170, 229.
67. Yim, C.C. and G.J. Mogenson, 1991, Electrophysiological evidence of modulatory interaction between dopamine and cholecystokinin in the nucleus accumbens, Brain Res. 541, 12.
68. Zarbin, M.A., R.B. Innis, J.K. Wansley, S.H. Snyder and M.J. Kuhar, 1983, Autoradiographic localization of cholecystokinin receptors in rodent brain, J. Neurosci. 3, 877.